Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

Sexuality The American Journal of Medicine

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

An Evidence-based Guide for Obesity Treatment in Primary Care

An Unusual Cause of Leg Ulcerations

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

An Evidence-based Guide for Obesity Treatment in Primary Care

Aruna D. Pradhan, MD, Nader Rifai, PhD, Julie E. Buring, ScD, Paul M

Predicting Survival in Oldest Old People

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc

Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H

Sudden Cardiac Death, Mitral Valve Prolapse, and Long QT Syndrome

Systematic Review of the Mediterranean Diet for Long-Term Weight Loss

Fraud in Academic Publishing: Researchers Under Cyber-Attacks

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Overview of Current Learning Theories for Medical Educators

Nisha I. Parikh, MD, MPH, Michael J. Pencina, PhD, Thomas J

The Long-term Effectiveness of a Lifestyle Intervention in Severely Obese Individuals Jessica L. Unick, PhD, Daniel Beavers, PhD, Dale S. Bond, PhD, Jeanne.

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

Bryan N. Becker, MD, Roger A. Formisano, PhD

A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness Salah Gariballa, MD, Sarah Forster, MSc, Stephen.

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes

Incident Gout in Women and Association with Obesity in the Atherosclerosis Risk in Communities (ARIC) Study Janet W. Maynard, MD, MHS, Mara A. McAdams.

Osteoporotic Fractures and Heart Failure in the Community

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Vasiliki V. Georgiopoulou, MD, Andreas P. Kalogeropoulos, MD, Bruce M

Apurva O. Badheka, MD, Ankit Rathod, MD, Mohammad A

Family History for Venous Thromboembolism and the Risk for Recurrence

The Reply The American Journal of Medicine

Jessica L. Lee, MD, MS, Esther S. Oh, MD, Rebecca W. Lee, MD, Thomas E

Karim M. Awad, MD, Atul Malhotra, Jodi H. Barnet, Stuart F

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

The Obesity Paradox, Weight Loss, and Coronary Disease

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Truman J. Milling, MD, Alex C. Spyropoulos, MD

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

The Obesity Paradox and Weight Loss

Repeated Hemoglobin A1C Ordering in the VA Health System

Persistent Insomnia is Associated with Mortality Risk

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Prevalence and Risk Factors for Erectile Dysfunction in the US

Does Testosterone Have a Role in Erectile Function?

Yoko Miyasaka, MD, PhD, Marion E. Barnes, MSc, Bernard J

National Trends in Ambulatory Oral Anticoagulant Use

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

A Post-cure Complication

Sister Mary Joseph's Node

The American Journal of Medicine

Primary Care Management of Skin Abscesses Guided by Ultrasound

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

The Association Between Barium Examination and Subsequent Appendicitis: A Nationwide Population-Based Study Hao-Ming Li, MD, Lee-Ren Yeh, MD, Ying-Kai.

Direct Observation of Residents: A Model for an Assessment System

Falls in Older Adults: Risk Assessment, Management and Prevention

Toward a More Responsible News Media

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Dean T. Eurich, PhD, Cheryl A. Sadowski, PharmD, Scot H

Presentation transcript:

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune, MSc, Peter Vestergaard, MD, PhD, DMSc The American Journal of Medicine Volume 118, Issue 5, Pages 489-495 (May 2005) DOI: 10.1016/j.amjmed.2005.01.031 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1(A) Cumulative incidence (Kaplan-Meier estimates) in men of atrial fibrillation or flutter according to category of body mass index at the baseline examination. The body mass index was 18.5–25 in normal subjects, 25–30 in overweight subjects, and 30 or more in obese subjects. The American Journal of Medicine 2005 118, 489-495DOI: (10.1016/j.amjmed.2005.01.031) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1(B) Cumulative incidence (Kaplan-Meier estimates) in women of atrial fibrillation or flutter according to category of body mass index at the baseline examination. The body mass index was 18.5–25 in normal subjects, 25–30 in overweight subjects, and 30 or more in obese subjects. The American Journal of Medicine 2005 118, 489-495DOI: (10.1016/j.amjmed.2005.01.031) Copyright © 2005 Elsevier Inc. Terms and Conditions